Bcl-2 is thought to associate spontaneously with membranes via a carboxyl-terminal hydrophobic domain by a mechanism analogous to that of cytochrome b5. We have examined the association of Bcl-2 with a variety of highly purified intracellular membranes in vitro. Fusion proteins were used to assess directly the role of the carboxyl-terminal hydrophobic domain of Bcl-2 in membrane association. Although this domain of Bcl-2 was sufficient to promote the association of a normally cytosolic polypeptide with either microsomal or mitochondrial membranes additional nonhydrophobic amino-terminal residues were required for membrane integration. Furthermore, direct comparison of membrane binding of Bcl-2 and cytochrome b5 revealed that similar to cytochrome b5, membrane targeting of Bcl-2 was not dependent on protease-sensitive components of the recipient membranes. In competition experiments, cytochrome b5 demonstrated the expected preference for integration into endoplasmic reticulum membranes. In contrast, the data presented here suggest that Bcl-2 is targeted to the cytoplasmic surface of multiple intracellular membranes, both in vitro and in human leukemic cells.
No takes yet. Share an insight, caveat, or question.
Janiak et al. (1994) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: